MetaboNews February: Dr. Xiuxia Du

The MetaboNews team conducted an insightful interview with Dr. Xiuxia Du from the University of North Carolina at Charlotte about her research and the current trend of metabolomics in the United States or, more generally, in North America. Dr. Du uses a wide range of disciplines in her work, including mathematics, statistics, signal processing, computer science, software engineering, and data science to develop computational algorithms, software tools, and web resources for mass spectrometry-based metabolomics and exposomics. Read the full interview here!

Components of an informatics pipeline for analyzing untargeted LC- and GC-MS metabolomics and exposomics data

Talking about the research in metabolomics and exposomics, the theme for the 4th Annual Canadian Metabolomics Conference (CanMetCon) 2023 will focus on “Exposomics”, advancing the understanding of exposures in Medicine, Agriculture/Food/ Cannabis, Environment/Industrial Settings, and Clinical Epigenomics. You have until March 31st to send in your abstract. If you register by March 14th, you only have to pay $150 CDN (for students) or $250 CAD (for everyone else). Sponsorship opportunities and the full program are available!

This year is an eventful year in the field of metabolomics, as evidenced by the recent announcement that the 19th Annual Conference of the Metabolomics Society will have five plenary talks delivered by Lorraine Brennan, Marja Lamoree, Gary Patti, Susan Murch, and Caroline Johnson, as well as the keynote speakers Sonia Anand, Takeshi Bamba, Anne Bendt, Ian Castro-Gamboa, Subhra Chakraborty, Rachel Kelly, María Eugenia Monge, Scott Smid, Justin van der Hooft, and Peter Würtz. 

In addition, the Metabolomics Association of North America (MANA) also announced the 5th Annual MANA Conference in partnership with the International Lipidomics Society (ILS). This conference will be held October 23-27, 2023 on the campus of the University of Missouri in Columbia, MO, United States, and chaired by Professor Lloyd Sumner.

Scroll to Top